312 related articles for article (PubMed ID: 21179004)
1. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.
Palii CG; Perez-Iratxeta C; Yao Z; Cao Y; Dai F; Davison J; Atkins H; Allan D; Dilworth FJ; Gentleman R; Tapscott SJ; Brand M
EMBO J; 2011 Feb; 30(3):494-509. PubMed ID: 21179004
[TBL] [Abstract][Full Text] [Related]
2. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
3. Dynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis.
Wu W; Morrissey CS; Keller CA; Mishra T; Pimkin M; Blobel GA; Weiss MJ; Hardison RC
Genome Res; 2014 Dec; 24(12):1945-62. PubMed ID: 25319994
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
5. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
6. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.
Kassouf MT; Hughes JR; Taylor S; McGowan SJ; Soneji S; Green AL; Vyas P; Porcher C
Genome Res; 2010 Aug; 20(8):1064-83. PubMed ID: 20566737
[TBL] [Abstract][Full Text] [Related]
8. Tal1/SCL binding to pericentromeric DNA represses transcription.
Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
[TBL] [Abstract][Full Text] [Related]
9. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
11. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.
Kuvardina ON; Herglotz J; Kolodziej S; Kohrs N; Herkt S; Wojcik B; Oellerich T; Corso J; Behrens K; Kumar A; Hussong H; Urlaub H; Koch J; Serve H; Bonig H; Stocking C; Rieger MA; Lausen J
Blood; 2015 Jun; 125(23):3570-9. PubMed ID: 25911237
[TBL] [Abstract][Full Text] [Related]
12. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.
Terme JM; Mocquet V; Kuhlmann AS; Zane L; Mortreux F; Wattel E; Duc Dodon M; Jalinot P
Leukemia; 2009 Nov; 23(11):2081-9. PubMed ID: 19587703
[TBL] [Abstract][Full Text] [Related]
14. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
Nie L; Wu H; Sun XH
J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
[TBL] [Abstract][Full Text] [Related]
16. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.
Tijssen MR; Cvejic A; Joshi A; Hannah RL; Ferreira R; Forrai A; Bellissimo DC; Oram SH; Smethurst PA; Wilson NK; Wang X; Ottersbach K; Stemple DL; Green AR; Ouwehand WH; Göttgens B
Dev Cell; 2011 May; 20(5):597-609. PubMed ID: 21571218
[TBL] [Abstract][Full Text] [Related]
18. The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.
Dey S; Curtis DJ; Jane SM; Brandt SJ
Mol Cell Biol; 2010 May; 30(9):2181-92. PubMed ID: 20194619
[TBL] [Abstract][Full Text] [Related]
19. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
[TBL] [Abstract][Full Text] [Related]
20. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
